Palmar-plantar erythrodysesthesia associated with capecitabine chemotherapy: a case report

Por Kigen, Gabriel, Busakhala, Naftali, Njiru, Evangeline, Chite, Fredrick, Loehrer, Patrick
Publicado no Pan Afr Med J (2015)

Critical role of NF-κB in pancreatic cancer

Por Prabhu, Lakshmi, Mundade, Rasika, Korc, Murray, Loehrer, Patrick J., Lu, Tao
Publicado no Oncotarget (2014)

Genetic pathways, prevention, and treatment of sporadic colorectal cancer

Por Mundade, Rasika, Imperiale, Thomas F., Prabhu, Lakshmi, Loehrer, Patrick J., Lu, Tao
Publicado no Oncoscience (2014)

Medical Education and Training: Building In-Country Capacity at All Levels

Por Chite Asirwa, Fredrick, Greist, Anne, Busakhala, Naftali, Rosen, Barry, Loehrer, Patrick J.
Publicado no J Clin Oncol (2016)

Mentoring future Kenyan oncology researchers

Por Moormann, Ann, Skiles, Jodi, Koros, Emmanuel, Asirwa, Fredrick Chite, Busakhala, Naftali, Loehrer, Patrick
Publicado em 2013

Clinical Practice Guidelines for Cancer Care: Utilization and Expectations of the Practicing Oncologist

Por Dillmon, Melissa, Goldberg, John M., Ramalingam, Suresh S., Mayer, Robert J., Loehrer, Patrick, Van Poznak, Catherine
Publicado em 2012

Phase I Study of Lenalidomide and Sorafenib in Patients With Advanced Hepatocellular Carcinoma

Por Shahda, Safi, Loehrer, Patrick J., Clark, Romnee S., Spittler, A. John, Althouse, Sandra K., Chiorean, E. Gabriella
Publicado no Oncologist (2016)

AIDS-Related Non-Hodgkin’s Lymphoma in Sub-Saharan Africa: Current Status and Realities of Therapeutic Approach

Por Mwamba, Peter M., Mwanda, Walter O., Busakhala, NaftaliW., Strother, R. Matthew, Loehrer, Patrick J., Remick, Scot C.
Publicado em 2012

A Randomized Trial of Two Print Interventions to Increase Colon Cancer Screening Among First-Degree Relatives

Por Rawl, Susan M., Champion, Victoria L., Scott, Linda L., Zhou, Honghong, Monahan, Patrick, Ding, Yan, Loehrer, Patrick, Skinner, Celette Sugg
Publicado em 2008

Epidermal Growth Factor Receptor, C-kit, and Her2/neu Immunostaining in Advanced or Recurrent Thymic Epithelial Neoplasms Staged According to the 2004 World Health Organization in...

Por Aisner, Seena C., Dahlberg, Suzanne, Hameed, Meera R., Ettinger, David S., Schiller, Joan H., Johnson, David H., Aisner, Joseph, Loehrer, Patrick J.
Publicado em 2010

Phase II Study of Carboplatin and Paclitaxel in Advanced Thymoma and Thymic Carcinoma

Por Lemma, Girum L., Lee, Ju-Whei, Aisner, Seena C., Langer, Corey J., Tester, William J., Johnson, David H., Loehrer, Patrick J.
Publicado em 2011

Phase II Trial of Erlotinib and Docetaxel in Advanced and Refractory Hepatocellular and Biliary Cancers: Hoosier Oncology Group GI06-101

Por Chiorean, E. Gabriela, Ramasubbaiah, Rashmi, Yu, Menggang, Picus, Joel, Bufill, Jose A., Tong, Yan, Coleman, Nicki, Johnston, Erica L., Currie, Colleen, Loehrer, Patrick J.
Publicado em 2012

Elevated Phospholipase A(2) Activities in Plasma Samples from Multiple Cancers

Por Cai, Hui, Chiorean, Elena G., Chiorean, Michael V., Rex, Douglas K., Robb, Bruce W., Hahn, Noah M., Liu, Ziyue, Loehrer, Patrick J., Harrison, Marietta L., Xu, Yan
Publicado em 2013

Molecular Analysis of Thymoma

Por Badve, Sunil, Goswami, Chirayu, Gökmen–Polar, Yesim, Nelson, Robert P., Henley, John, Miller, Nick, Zaheer, Narjis A., Sledge, George W., Li, Lang, Kesler, Kenneth A., Loehrer, Patrick J.
Publicado em 2012

Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial

Por Loehrer, Patrick J., Feng, Yang, Cardenes, Higinia, Wagner, Lynne, Brell, Joanna M., Cella, David, Flynn, Patrick, Ramanathan, Ramesh K., Crane, Christopher H., Alberts, Steven R., Benson, Al B.
Publicado em 2011

Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors

Por Giaccone, Giuseppe, Rajan, Arun, Berman, Arlene, Kelly, Ronan J., Szabo, Eva, Lopez-Chavez, Ariel, Trepel, Jane, Lee, Min-Jung, Cao, Liang, Espinoza-Delgado, Igor, Spittler, John, Loehrer, Patrick J.
Publicado em 2011

Oral 1.01: Phase II trial of amrubicin in patients with previously treated advanced thymic malignancies

Por Wakelee, Heather A., Padda, Sukhmani K., Burns, Matthew, Spittler, A. J., Riess, Jonathan W., San Pedro-Salcedo, Melanie, Ramchandran, Kavitha J., Gubens, Matthew A., Neal, Joel W., Loehrer, Patrick J.
Publicado no J Thorac Dis (2015)

A large microRNA cluster on chromosome 19 is a transcriptional hallmark of WHO type A and AB thymomas

Por Radovich, Milan, Solzak, Jeffrey P, Hancock, Bradley A, Conces, Madison L, Atale, Rutuja, Porter, Ryan F, Zhu, Jin, Glasscock, Jarret, Kesler, Kenneth A, Badve, Sunil S, Schneider, Bryan P, Loehrer, Patrick J
Publicado no Br J Cancer (2016)

Contribution of Environment and Genetics to Pancreatic Cancer Susceptibility

Por Hocevar, Barbara A., Kamendulis, Lisa M., Pu, Xinzhu, Perkins, Susan M., Wang, Zheng-Yu, Johnston, Erica L., DeWitt, John M., Li, Lang, Loehrer, Patrick J., Klaunig, James E., Chiorean, E. Gabriela
Publicado em 2014

A Gene Signature to Determine Metastatic Behavior in Thymomas

Por Gökmen-Polar, Yesim, Cook, Robert W., Goswami, Chirayu Pankaj, Wilkinson, Jeff, Maetzold, Derek, Stone, John F., Oelschlager, Kristen M., Vladislav, Ioan Tudor, Shirar, Kristen L., Kesler, Kenneth A., Loehrer, Patrick J., Badve, Sunil
Publicado em 2013